glp 1 in germany Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - based therapies: An expert consensus statement using a modified Delphi approach Export of Novo Nordisk's Ozempic

Unlike insurance claims data, which tend to reflect usage among diabetic or obese patients with treatment covered by insurance, Numerators data also capture households that use GLP-1 drugs off-label, including many who pay out of pocket and do not meet the clinical criteria for obesity, providing a broader view of adoption patterns

GLP-1 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 - Landscape Led by China and the U.S., Rising Partnerships, and Strong DTC-Driven Demand Push Biologics Above 65% Share The GLP-1 market is primed for substantial growth due to rising obesity and diabetes rates

Supplementary Material 2 Peptide Identification List

The analysis is designed to help consumers understand how clinicians typically evaluate GLP-1 treatment eligibility, safety considerations, and access pathways rather than to rank medications or recommend specific prescriptions

Download my FREE 50 step checklist to triathlon nutrition mastery